United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD

Key facts

  • United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD
  • United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.

Citation
United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 8, 2026 at 08:00 (1631h 0m after Published)
  • 🤖 AI Analyzed: May 8, 2026 at 08:15 (15 min after Collected)
Company Code: 4119
Company Name: United Biopharmaceutical Inc.
Industry: Biotechnology and Healthcare
Year/Quarter: 2026 Q1
Basic EPS: 0.17 NTD
Revenue: 376 million NTD
Net Profit: 20 million NTD
Keywords: Financials, Biotechnology, EPS

FAQ

What are the key facts in this article?

United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.

What is the direct answer?

United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-4119-2026Q1 | March 1, 2026

Back to Newsroom (15)